Cell type-specific KSHV entry mediators for infection of epithelia and fibroblasts
Cell type-specific KSHV entry mediators for infection of epithelia and fibroblasts
批准号:
512328936
负责人:
Dr. Alexander Hahn
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Kaposi’s sarcoma-associated herpesvirus (KSHV) is a major cause of morbidity and mortality in Sub-Saharan Africa and poses a threat to immunocompromised individuals worldwide. KSHV enters host cells through mechanisms involving a variety of interactions of viral glycoproteins with cellular receptors, among those the interaction with integrins through glycoprotein B and the interaction with molecules of the Eph family of receptor tyrosine kinases through the gH/gL glycoprotein complex. Previous studies from our group and others have shown that, while important, these known receptor interactions do not fully explain KSHV entry into host cells, also depending on the target cell. We therefore focused on the less well-studied glycoprotein K8.1, a highly glycosylated and immunogenic protein of the KSHV envelope. We observed that deletion of the gene coding for K8.1 leads to strongly reduced infectivity on epithelial cells. We speculated that this is due to the interaction of K8.1 with a so-far unknown receptor on these cells and therefore have identified a number of K8.1-interacting cellular proteins by affinity purification and mass spectrometry that we will now test for function in the KSHV entry process through gene knockout. We will further pinpoint the exact function of K8.1 and its interaction with cellular receptors with regard to the attachment step, endocytosis, and membrane fusion. In a second approach, we performed preliminary studies to identify cellular proteins that interact with the known KSHV entry receptor EphA2. We identified both known and novel interactors and analyzed these candidates through gene knockout. Knockout of one of these factors, a small GTPase-binding protein, caused a significant reduction in the susceptibility to KSHV infection of a number of different cell lines and primary cells, but not of all cells that were tested. The reduction in infection upon knockout was most pronounced in fibroblasts but not observable e.g. in an epithelial cell line. We now want to study the exact function of this GTPase-binding protein for both endocytosis of KSHV and of the EphA2 receptor.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of SARS-CoV-2 by antibodies to the proteolytic cleavage sites of the spike protein
-
批准号:458682915
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Dr. Alexander Hahn
-
依托单位:
Rhadinovirus Receptors - Structure, Signaling, and Cell Tropism
-
批准号:393153343
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Dr. Alexander Hahn
-
依托单位:
Rhadinovirus Entry
-
批准号:163662522
-
项目类别:Research Fellowships
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Dr. Alexander Hahn
-
依托单位:
Glycoproteins and Entry into Host Cells – Structure and Function of the KSHV fusion machinery
-
批准号:530009014
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Dr. Alexander Hahn
-
依托单位:
国内基金
海外基金
登录
查看更多内容
铋基邻近双金属位点Type B异质结光热催化合成氨机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:黎景卫
-
依托单位:
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
-
批准号:82372202
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯旭敏
-
依托单位:
损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
-
批准号:82371721
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王星云
-
依托单位:
GPSM1介导Ca2+循环-II型肌球蛋白网络调控脂肪产热及代谢稳态的机制研究
-
批准号:82370879
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:严婧
-
依托单位:
二型聚合函数基于扩展原理的构造与表示问题
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:张炜
-
依托单位:
真菌中I型-III型聚酮杂合类天然产物的基因组挖掘
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:孔德坤
-
依托单位:
智能型Type-I光敏分子构效设计及其抗耐药性感染研究
-
批准号:22207024
-
项目类别:青年科学基金项目(C类)
-
资助金额:20.0万元
-
批准年份:2022
-
负责人:赵琦
-
依托单位:
TypeⅠR-M系统在碳青霉烯耐药肺炎克雷伯菌流行中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:蒋晓飞
-
依托单位:
替加环素耐药基因 tet(A) type 1 变异体在碳青霉烯耐药肺炎克雷伯菌中的流行、进化和传播
-
批准号:LY22H200001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:蔡加昌
-
依托单位:
面向手性α-氨基酰胺药物的新型不对称Ugi-type 反应开发
-
批准号:LY22B020003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:李绍玉
-
依托单位: